COMT genotype predicts cortical-limbic D1 receptor availability measured with [11C]NNC112 and PET

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• The catechol-O-methyltransferase (COMT) Val158Met polymorphism influences dopamine (DA) levels and cortical function.
• Reduced cortical DA is linked to increased D1 receptor availability, measurable with [11C]NNC112 PET scans.

Purpose of the Study:

• To compare [11C]NNC112 binding in healthy volunteers with Val/Val genotype versus Met carriers.
• To investigate the role of COMT in regulating cortical and striatal dopamine transmission.

Main Methods:

• Positron-emission tomography (PET) using the radiotracer [11C]NNC112.
• Comparison of [11C]NNC112 binding in healthy volunteers stratified by COMT Val158Met genotype (Val/Val vs. Met carriers).
• Subjects were matched for known confounding factors.

Main Results:

• Significantly higher cortical [11C]NNC112 binding was observed in Val/Val individuals compared to Met carriers.
• No significant difference in striatal [11C]NNC112 binding was found between the groups.
• These findings support the role of COMT in cortical, but not striatal, dopamine regulation.

Conclusions:

• The COMT Val158Met polymorphism significantly affects cortical D1 receptor availability.
• [11C]NNC112 reliably indicates low dopamine tone in the cortex.
• COMT plays a crucial role in regulating cortical dopamine transmission.